A put up hoc analyses of the RIM trial assessed the efficacy of rituximab with the cutaneous manifestations of adult DM and JDM [31]. Within this analysis, benefits showed sizeable enhancement in cutaneous disease https://darrennalk676605.ziblogs.com/profile